GLP-1 medications more commonly known by their brand names Ozempic, Mounjaro, and Wegovy are being used by diabetic patients as well as weight loss patients to help reduce feelings of hunger
Both the injectable and oral forms of semaglutide have a half-life of about one week
Learning and memory are fundamental to cognitive functions that allow us to acquire, store, and retrieve information
Below, we explore how telehealth is redefining GLP-1 managementmaking it more accessible, convenient, and sustainable for patients nationwide
Serious adverse events are rare, and these medications do not interact dangerously with each other
JPMorgan researchers estimate that the number will balloon, with 30 million people expected to be taking GLP-1 drugs by 2030, or around 9 percent of the US population